Kaleido Biosciences, Inc.

KLDOOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$4262

P/E Ratio—

52W High$0.19

52W Low$0.00001

Avg Volume2K

Open$0.00

Beta-1.17

Forecast Market Cap PE Ratio

Kaleido Biosciences, Inc.（KLDO）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

kldo · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 7 位华尔街分析师

Buy

7 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 7 · 买入占比: 57.1%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.00

Kaleido Biosciences, Inc.（KLDO）的分析师共识为 Buy，基于过去 3 个月内 7 位华尔街分析师的评级。KLDO 的 12 个月平均目标价为 $0.00，相对当前价 $0.00 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$0.00	↑ 0.00%	$0.00	$0.00

1-day model range: $0–$0. Peak: $0 (+0.00%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

0%100%0%

0Buy

14Neutral

0Sell

RSI (14)50.0Neutral

MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · KLDO · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$0.00NEUTRAL

MA 10$0.00NEUTRAL

MA 20$0.00NEUTRAL

MA 50$0.00NEUTRAL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $KLDO · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$0.00NEUTRAL

EMA 10$0.00NEUTRAL

EMA 20$0.00NEUTRAL

EMA 50$0.00NEUTRAL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $KLDO · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2022-04-04	Chardan Capital	Downgrade ↓	Buy→Neutral
2022-01-31	Chardan Capital	Maintains	Buy→Buy
2021-11-12	Chardan Capital	Maintains	Buy→Buy
2021-11-03	JMP Securities	Maintains	Market Outperform→Market Outperform
2021-10-19	Morgan Stanley	Downgrade ↓	Equal Weight→Underweight
2021-03-08	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2021-02-09	Piper Sandler	Maintains	Overweight→Overweight
2021-01-19	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2020-12-23	JMP Securities	Maintains	Outperform→Outperform
2020-08-10	Morgan Stanley	Maintains	Equal Weight→Equal Weight

Chardan Capital2022-04-04

Downgrade ↓

Buy→Neutral

Chardan Capital2022-01-31

Maintains

Buy→Buy

Chardan Capital2021-11-12

Maintains

Buy→Buy

JMP Securities2021-11-03

Maintains

Market Outperform→Market Outperform

Morgan Stanley2021-10-19

Downgrade ↓

Equal Weight→Underweight

Morgan Stanley2021-03-08

Maintains

Equal Weight→Equal Weight

Piper Sandler2021-02-09

Maintains

Overweight→Overweight

Morgan Stanley2021-01-19

Maintains

Equal Weight→Equal Weight

JMP Securities2020-12-23

Maintains

Outperform→Outperform

Morgan Stanley2020-08-10

Maintains

Equal Weight→Equal Weight

Wall Street analysts have recently issued updated ratings on Kaleido Biosciences, Inc. (KLDO) stock. Of the recent 17 rating actions, 0 were upgrades and 3 were downgrades. 7 analysts currently cover KLDO.

分析师推荐趋势

Buy ratings1 → 0↓ 1

Hold ratings0 → 1↑ +1

Sell ratings0 → 0

KLDO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$2M

↓ 94.4% YoY

Revenue Next Year

$1M

↓ 40.1% YoY

EPS This Year

$-2.26

EPS Next Year

$-1.16

↓ 48.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast KLDO EPS of $-2.26 for the current fiscal year, based on estimates from 1 analysts. The KLDO revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

KLDO 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KLDO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

KLDO 的短期预测（明日）为 $0.00（+0.00%）。

Kaleido Biosciences, Inc. 在 OTC 上市，代码 KLDO。KLDO 在 2027 年的整体展望偏积极，在覆盖分析师中约 57% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

KLDO 预测 · 8 个问题

根据 7 位华尔街分析师，KLDO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.00，隐含约 +0.0% 的上行空间。

KLDO 目标价KLDO 分析师目标价KLDO 12个月目标价目标价 KLDO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.